Elevated miRNA 9 levels in patients with T2D and its positive correlation with FPG could be explained as miRNA 9 targets Onecut 2 a transcription factor[20], which decreases Granuphilin (a negative regulatory element of the exocytotic process of insulin) [21], [22]. The gene discussed is SYTL4; the disease is type 2 diabetes mellitus.